Primary gastrointestinal tract lymphoma: Diagnosis and management of common neoplasms

Expert Review of Anticancer Therapy

Volumn 6, Issue 11, 2006, Pages 1609-1628

  Dickson, Brendan C ^a   Serra, Stefano ^a   Chetty, Runjan ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Diagnosis; Gastrointestinal; Lymphoma; MeSH headings; Pathology; Primary; Review treatment

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTHRACYCLINE DERIVATIVE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; METRONIDAZOLE; PREDNISONE; PROTON PUMP INHIBITOR; RITUXIMAB; TETRACYCLINE; VINCRISTINE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BURKITT LYMPHOMA; CASE MANAGEMENT; CLINICAL TRIAL; FOLLICULAR LYMPHOMA; GASTROINTESTINAL TUMOR; HELICOBACTER INFECTION; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; MOLECULAR BIOLOGY; MORPHOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOPHYSIOLOGY; PLASMACYTOMA; REVIEW; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

COLONIC NEOPLASMS; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; LYMPHOMA, FOLLICULAR; PEYER'S PATCHES; STOMACH NEOPLASMS;

EID: 33845360387     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.6.11.1609     Document Type: Review

References (196)

1. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 36(1), 69-86 (2000).
2. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkins lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J. Natl Cancer Inst. 92(15), 1240-1251 (2000).
3. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann. Oncol. 8(8), 727-737 (1997).
4. Isaacson PG. Update on MALT lymphomas. Best Pract. Res. Clin. Haematol. 18(1), 57-68 (2005).
5. Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br. J. Surg. 49, 80-89 (1961).
6. Wotherspoon A, Chott A, Gascoyne RD, Muller-Hermelink HK. Lymphoma of the oesophagus. In: Pathology and Genetics: Tumours of the Digestive System. Hamilton SR, Aaltonen LA (Eds). IARCPress, Lyon, France, 27 (2000).
7. Wotherspoon A, Chott A, Gascoyne RD, Muller-Hermelink HK. Lymphoma of the stomach. In: Pathology and Genetics: Tumours of the Digistive System. Hamilton SR, Aaltonen LA (Eds). IARCPress, Lyon, France, 57-61 (2000).
8. Gascoyne RD, Muller-Hermelink HK, Chott A, Wotherspoon A. B-cell lymphoma of the small intestine. In: Pathology and Genetics: Tumours of the Digestive System. Hamilton SR, Aaltonen LA (Eds). IARCPress, Lyon, France, 83-86 (2000).
9. Muller-Hermelink HK, Chott A, Gascoyne RD, Wotherspoon A. B-cell lymphoma of the colon and rectum. In: Pathology and Genetics: Tumours of the Digestive System. Hamilton SR, Aaltonen L (Eds). IARCPress, Lyon, France, 139-141 (2000).
10. Isaacson PG. Primary gastric lymphoma. Pathol. Oncol. Res. 2(1-2), 5-10 (1996).
11. Isaacson PG. Recent developments in our understanding of gastric lymphomas. Am. J. Surg. Pathol. 20(Suppl. 1), S1-S7 (1996).
12. Mendelson RM, Fermoyle S. Primary gastrointestinal lymphomas: a radiological-pathological review. Part 1: stomach, oesophagus and colon. Australas. Radiol. 49(5), 353-364 (2005).
13. Golioto M, McGrath K. Primary lymphoma of the esophagus in a chronically immunosuppressed patient with hepatitis C infection: case report and review of the literature. Am. J. Med. Sci. 321 (3), 203-205 (2001).
14. Gupta NM, Goenka MK, Jindal A, Behera A, Valphei K. Primary lymphoma of the esophagus. J. Clin. Gastroenterol. 23(3), 203-206 (1996).
15. Isaacson PG. Gastrointestinal lymphomas of T- and B-cell types. Mod. Pathol. 12(2), 151-158 (1999).
16. Fischbach W, Kestel W, Kirchner T, Mossner J, Wilms K. Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer 70(5), 1075-1080 (1992).
17. Nakamura S, Matsumoto T, Takeshita M et al. A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Carncer 88(2), 286-294 (2000).
18. Zighelboim J, Larson MV. Primary colonic lymphoma. Clinical presentation, histopathologic features, and outcome with combination chemotherapy. J. Clin. Gastroenterol. 18(4), 291-297 (1994).
19. Naqvi MS, Burrows L, Kark AE. Lymphoma of the gastrointestinal tract: prognostic guides based on 162 cases. Ann. Surg. 170(2), 221-231 (1969).
20. Doolabh N, Anthony T, Simmang C et al. Primary colonic lymphoma. J Surg. Oncol. 74(4), 257-262 (2000).
21. DeNardi FG, Riddell RH. The normal esophagus. Am. J. Surg. Pathol. 15(3), 296-309 (1991).
22. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann. Surg. 194(4), 438-446 (1981).
23. Coppens E, El Nakadi I, Nagy N, Zalcman M. Primary Hodgkin's lymphoma of the esophagus. Am. J. Roentgenol. 180(5), 1335-1337 (2003).
24. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 205(2), 255-274 (2005).
25. Kusic B, Gasparov S, Katicic M, Dominis M, Antica M. Monoclonality in Helicobacter pylori-positive gastric biopsies: an early detection of mucosa-associated lymphoid tissue lymphoma. Exp. Mol. Pathol. 74(l), 61-67 (2003).
26. Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 3(2), 97-104 (2002).
27. Listrom, MB, Fenoglio-Preiser CM. Lymphatic distribution of the stomach in normal, inflammatory, hyperplastic, and neoplastic tissue. Gastroenterology 93(3), 506-514 (1987).
28. Owen DA. Normal histology of the stomach. Am. J. Surg. Pathol. 10(l), 48-61 (1986).
29. Dickson BC, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists. J. Clin. Pathol. 59(10), 1008-1016 (2006).
30. Chang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. Acta Pathol. Microbiol. Immunol. Scand. 113(6), 385-399 (2005).
31. Cheroutre H. IELs: enforcing law and order in the court of the intestinal epithelium. Immunol. Rev 206, 114-131 (2005).
32. Moghaddami M, Cummins A, Mayrhofer G. Lymphocyte-filled villi: comparison with other lymphoid aggregations in the mucosa of the human small intestine. Gastroenterology 115(6), 1414-1425 (1998).
33. Fenoglio-Preiser C. Gastrointestinal Pathology: An Atlas and Text Lippincott Williams & Wilkins, PA, USA (1997).
34. Segal GH, Petras RE. Small intestine. In: Histology for Pathologists Sternberg SS (Ed.). Lippincott Williams & Wilkins, PA, USA 495-518 (1998).
35. Fenoglio-Preiser CM. Gastrointestinal Pathology: An Atlas and Text. Lippincott Williams & Wilkins, PA, USA (1988).
36. Unthank JL, Bohlen HG. Lymphatic pathways and role of valves in lymph propulsion from small intestine. Am. J. Physiol. 254(3 Pt 1), G389-G398 (1998).
37. Day DW, Jass JR, Price AB et al. Morson and Dawson's Gastrointestinal Pathology, Fourth Edition. Blackwell Publishing, MA, USA (1997).
38. Levine DS, Haggitt RC. Colon. In: Histology for Pathologists Second Edition. Sternberg SS (Ed.). Lippincott Williams & Wilkins, PA, USA 519-537 (1997).
39. Kojima M, Itoh H, Motegi A, Sakata N, Masawa N. Localized lymphoid hyperplasia of the rectum resembling polypoid mucosa-associated lymphoid tissue lymphoma: a report of three cases. Pathol. Res. Pract. 201(11), 757-761 (2005).
40. Fogt E, Pascha TL, Zhang PJ, Gausas RE, Rahemtulla A, Zimmerman RL. Proliferation of D2-40-expressing intestinai lymphatic vessels in the lamina propria in inflammatory bowel disease. Int. J. Mol. Med. 13(2), 211-214 (2004).
41. Fogt F, Zimmerman RL, Ross HM, Daly T, Gausas RE. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol. Rep. 11(l), 47-50 (2004).
42. Jamieson JK, Dobson JF. Lymphatics of the colon with special reference to the operative treatment of cancer of the colon. Ann. Surg. 50(6), 1077-1090 (1909).
43. Meyers MA. Dynamic radiology of the abdomen: normal and pathologic anatomy. Springer, NY, USA (2002)
44. Stolte M, Bayerdorffer E, Morgner A et al. Helicobacter and gastric MALT lymphoma. Gut50(Suppl. 3), 19-24 (2000).
45. Hosaka S, Nakamura N, Akamatsu T et al. A case of primary low grade mucosa associated lymphoid tissue (MALT) lymphoma of the oesophagus. Gut 51 (2), 281-284 (2002).
46. Kitamoto Y, Hasegawa M, Ishikawa H Saito J, Yamakawa M, Kojima M, Nakano T. Mucosa-associated lymphoid tissue lymphoma of the esophagus: a case report. J. Clin. Gastroenterol. 36(5), 414-416 (2003).
47. Campo E, Chott A, Kinney MC et al. Update on extranodal lymphomas. Conclusions of the workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology 48(5), 481-504 (2006).
48. Grunberger B, Wohrer S, Streubel B et al. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J. Clin. Oncol. 24(9), 1370-1375 (2006).
49. Hummel M, Oeschger S, Barth TF et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut 55(6), 782-787 (2006).
50. Isaacson PG, Muller-Hermelink HK, Piris MA et al. Extranodal marginal zone B-cell lymphoma of mucosal-associated lymphoid tissue (MALT lymphoma). In: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARCPress, Lyon, France, 157-160 (2001).
51. Ye H, Liu H, Raderer M et al. High incidence of t(11;18) (q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 101(7), 2547-2550 (2003).
52. Jhala D, Jhala N, Lechago J, Haber M. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis. Mod. Pathol. 12(5), 534-538 (1999).
53. Morgner A, Lehn N, Andersen LP et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 118(5), 821-828 (2000).
54. Nakase H, Okazaki K, Ohana M et al. The possible involvement of microorganisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients. Endoscopy 34(4), 343-346 (2002).
55. Streubel B, Seltz G, Stolte M, Birner P, Chott A, Raderer M. MALT lymphoma-associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas. Gut 55(11), 1581-1585 (2005)
56. Chung JJ, Kim MJ, Kie JH, Kim KW. Mucosa-associated lymphoid tissue lymphoma of the esophagus coexistent with bronchus-associated lymphoid tissue lymphoma of the lung. Yonsei Med. J. 46(4), 562-566 (2006).
57. Miyazaki T, Kato H, Masuda N et al. Mucosa-associated lymphoid tissue lymphoma of the esophagus: case report and review of the literature. Hepatogastroenterology 51(57), 750-753 (2004).
58. Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management Gut 55(6), 886-893 (2006).
59. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgdkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89(11), 3909-3918 (1997).
60. Kolve M, Fischbach W, Greiner A, Wilms K. Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin's lymphoma. German Gastrointestinal Lymphoma Study Group. Gastrovintest. Endosc. 49(3 Pt 1), 307-315 (1999).
61. Chim, CS, Shek TW Chung LP, Ho J. Gut perforation in MALT lymphoma of colon. Haematologica 87(4), EIM15 (2002).
62. Romaguera J, Hagemeister FB. Lymphoma of the colon. Curr. Opin. Gastroenterol. 21(1), 80-84 (2005).
63. Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 20(1), 29-34 (1992).
64. Wotherspoon AC, Ortiz-Hidalgo, C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and prinriary B-oell gastric lymphoma. Lancet 338(8776), 1175-1176 (1991).
65. Zettl A, Rudiger T, Marx A, Muller-Hermelink HK, Ott G. Composite marginal zone B-cell lymphoma and classical Hodgkins lymphoma: a clinicopathological study of 12 cases. Histopathology 46(2), 217-228 (2005).
66. Raderer M, Vorbeck F, Formanek M et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br. J. Cancer 83(4), 454-457 (2000).
67. Nakamura S, Matsumoto T, Suekane H et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 48(4), 454-460 (2001).
68. Raderer M, Wohrer S, Streubel B et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J. Clin. Oncol. 24(19), 3136-3141 (2006).
69. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53(1), 34-37 (2004).
70. Fischbach W, Goebeler-Kolve ME, Greiner A. Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage. Gastrointest. Endosc. 56(5), 696-700 (2002).
71. Ford A, Moayyedi P. How can the current strategies for Helicobacter pylori eradication therapy be improved? Can. J. Gastroenterol. 17(Suppl. B), B36-B40 (2003).
72. Yamashita H, Watanabe H, Ajioka Y, Nishikura K, Maruta K, Fujino MA. When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after Helicobacter pylori eradication? Histopathology 37(2), 131-140 (2000).
73. Morgner A, Bayerdorffer E, Neubauer A, Stolte M. Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease. Microsc. Res. Tech. 48(6), 349-356 (2000).
74. Fischbach W, Goebeler-Kolve M, Starostik P, Greiner A, Muller-Hermelink HK. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 360(9332), 547-548 (2002).
75. Copie-Bergman C, Locher C, Levy M et al. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann. Oncol. 16(8), 1232-1236 (2005).
76. Akamatsu T, Mochizuki T, Okiyama Y, Matsumoto A, Miyabayashi H, Ota H. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter 11(2), 86-95 (2006).
77. Koch P, Probst A, Berdel WE et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J. Clin. Oncol. 23(28), 7050-7059 (2005).
78. Yoon SS, Coit DG, Portlock CS, Karpeh MS. The diminishing role of surgery in the treatment of gastric lymphoma. Ann. Surg. 240(1), 28-37 (2004).
79. Aviles A, Nambo MJ, Neri N, Talavera A, Cleto S. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med. Oncol. 22(1), 57-62 (2005).
80. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J. Clin. Oncol. 16(5), 1916-1921 (1998).
81. Fischbach W, Dragosics B, Kolve-Goebeler ME et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 119(5), 1191-1202 (2000).
82. Alpen B, Kuse R, Parwaresch R, Muller-Hermelink HK, Stolte M, Neubauer A. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy. J. Clin. Oncol. 22(15), 3039-3045 (2004).
83. Raderer M, Streubel B, Woehrer S et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin. Cancer Res. 11(9), 3349-3352 (2005).
84. Diz-Lois Palomares MT, Souto Ruzo J, Yanez Lopez JA, Alvarez Garcia A, Arnal Monreal F, Vazquez-Iglesias JL. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome. Rev. Esp. Enferm. Dig. 94(11), 669-678 (2002).
85. Arima N, Tsudo M. Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br. J. Haematol. 120(5), 790-792 (2003).
86. Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J. Clin. Oncol. 23(26), 6415-6420 (2005).
87. Zucca E, Conconi A, Cavalli F. Treatment of extranodal lymphomas. Best Pract. Res. Clin. Haematol. 15(3), 533-547 (2002).
88. McLaughlin P, Hagemeister FB, Romaguera JE et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. J. Clin. Oncol. 14(4), 1262-1268 (1996).
89. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 105(6), 2274-2280 (2005).
90. Lecuit M, Abachin E, Martin A et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350(3), 239-248 (2004).
91. Odze RD, Goldblum JR, Crawford JM. Surgical Pathology of the GI Tract, Liver, Billary Tract, and Pancreas. Elsevier Health Sciences, PA, USA (2002).
92. Schiller LH. Malabsorption disorders. In: Current Diagnosis and Treatment in Gastroenterology. Friedman SL, McQuaid KR, Grendell JH (Eds). McGraw-Hill, NY, USA 368-388 (2003).
93. Salimi M, Spinelli JJ. Chemotherapy of Mediterranean abdominal lymphoma. Retrospective comparison of chemotherapy protocols in Iranian patients. Am. J. Clin. Oncol. 19(1), 18-22 (1996).
94. Fischbach W, Tacke W, Greiner A, Konrad H, Muller H. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 349, 31-32 (9044) (1997).
95. Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J. Clin. Oncol. 23(26), 6364-6369 (2005).
96. Hashimoto Y, Nakamura N, Kuze T, Ono N, Abe M. Multiple lymphomatous polyposis of the gastrointestinal tract is a heterogenous group that includes mantle cell lymphoma and follicular lymphoma: analysis of somatic mutation of immunoglobulin heavy chain gene variable region. Hum. Pathol. 30(5), 581-587 (1999).
97. Raderer M, Puspok A, Birkner T, Streubel B, Chott A. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease. Leuk. Lymphoma 45(7), 1459-1462 (2004).
98. Andersen NS, Jensen MK, de Nully Brown P, Geisler CH. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur. J. Cancer 38(3), 401-408 (2002).
99. Leonard JP, Schattner EJ, Coleman M. Biology and management of mantle cell lymphoma. Curr. Opin. Oncol. 13(5), 342-347 (2001).
100. Swerdlow SH, Berger F, Isaccson PG et al. Mantle cell lymphoma. In: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. IARCPress, Lyon, France, 168-170 (2001).
101. Hurlstone DP. Early phase mantle cell lymphoma: macroscopic similarities to terminal ileal Crohn's disease. Am. J. Gastroenterol. 97(6), 1577-1578 (2002).
102. Tsuchiyama J, Yoshino T, Imajo K et al. Lymphomatous polyp of mantle cell type in the duodenum complicated by gastric cancer: a case of trisomy 3 and t(11;14) (q13;q32). Ann. Hematol. 81(4), 224-227 (2002).
103. Ruskone-Fourmestraux A, Delmer A, Lavergne A et al. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'etude des Lymphomes Digestifs. Gastroenterology 112(1), 7-16 (1997).
104. Tamura S, Ohkawauchi K, Yokoyama Y et al. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract. J. Gastroenterol. 39(10), 995-1000 (2004).
105. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5), 1361-1392 (1994).
106. Witzig TE. Current treatment approaches for mantle-cell lymphoma. J. Clin. Oncol. 23(26), 6409-6414 (2005).
107. Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11(4), 375-383 (2006).
108. Diebold J, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARCPress, Lyon, France, 181-184 (2001).
109. Sharma A, Raina V, Gujral S, Kumar R, Tandon R, Jain P, Burkitt's lymphoma of stomach: a case report and review of literature. Am. J. Hematol. 67(1), 48-50 (2001).
110. Andoh A, Takaya H, Bamba M et al. Primary gastric Burkitt's lymphoma presenting with c-myc gene rearrangement. J. Gastroenterol. 33(5), 710-715 (1998).
111. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 104(10), 3009-3020 (2004).
112. Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J. Clin. Oncol. 18(21), 3707-3721 (2000).
113. Song KW, Barnett MJ, Gascoyne RD et al. Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma. Br. J. Haematol. 133(6), 634-637 (2006).
114. Tzankov A, Hittmair A, Muller-Hermelink HK, Rudiger T, Dirnhofer S. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT. Virchows Arch. 441(6), 614-617 (2002).
115. Narita M, Yatabe Y, Asai J, Mori N. Primary gastric lymphomas: morphologic, immunohistochemical and immunogenetic analyses. Pathol. Int. 46(9), 623-629 (1996).
116. Shia J, Teruya-Feldstein J, Pan D et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am. J. Surg. Pathol. 26(2), 216-224 (2002).
117. Damaj G, Verkarre V, Delmer A et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann. Oncol. 14(4), 623-629 (2003).
118. Yoshino T, Ichimura K, Mannami T et al. Multiple organ mucosa-associated lymphoid tissue lymphomas often involve the intestine. Cancer 91(2), 346-353 (2001).
119. Kodama T, Ohshima K, Nomura K et al Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology 47(5), 467-478 (2005).
120. Yoshino T, Miyake K, Ichimura K et al. Increased incidence of follicular lymphoma in the duodenum. Am. J. Surg. Pathol. 24(5), 688-693 (2000).
121. Nathwani BN, Harris NL, Weisenburger D et al. Follicular lymphoma. In: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARCPress, Lyon, France, 162-167 (2001).
122. Freeman HJ, Anderson ME, Gascoyne RD. Clinical, pathological and molecular genetic findings in small intestinal follicle centre cell lymphoma. Can. J. Gastroenterol. 11(1), 31-34 (1997).
123. Chim CS, Loong F, Leung AY, Tsang J, Ooi GC. Primary follicular lymphoma of the small intestine. Leuk. Lymphoma 45(7), 1463-1466 (2004).
124. Colombat P, Salles G, Brousse N et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood97(1), 101-106 (2001).
125. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARCPress, Lyon, France, 171-174 (2001).
126. Pileri SA, Dirnhofer S, Went P et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology 41(6), 482-509 (2002).
127. Sumi M, Takaku T, Iguchi T et al. Primary diffuse large B-cell lymphoma of the esophagus. Rinsho Ketsueki 45(9), 1067-1069 (2004).
128. Weeratunge CN, Bolivar HH, Anstead GM, Lu DH. Primary esophageal lymphoma: a diagnostic challenge in acquired immunodeficiency syndrome - two case reports and review. South Med. J. 97(4), 383-387 (2004).
129. Starostik P, Patzner J, Greiner A et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 99(1), 3-9 (2002).
130. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am. J. Pathol. 136(5), 1153-1164 (1990).
131. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 101(5), 1159-1170 (1991).
132. Binn M, Ruskone-Fourmestraux A, Lepage E et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann. Oncol. 14(12), 1751-1757 (2003).
133. Wohrer S, Bartsch R, Hejna M, Drach J, Raderer M. Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy. Scand. J. Gastroenterol. 40(10), 1222-1225 (2005).
134. Spectre G, Libster D, Grisariu S et al. Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy. Ann. Surg. Oncol. (2006) (Epub ahead of print).
135. Raderer M, Chott A, Drach J et al. Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann. Oncol. 13(7), 1094-1098 (2002).
136. E. Cancer 88(9), 1979-1985 (2000).
137. Aviles A, Nambo MJ, Neri N et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann. Surg. 240(1), 44-50 (2004).
138. Aviles A, Neri N, Delgado S et al. Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy. Med. Oncol. 22(4), 383-387 (2005).
139. Aviles A, Delgado S, Nambo MJ, Alatriste S, Diaz-Maqueo JC. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. Int J. Radiat. Oncol. Biol. Phys. 30(4), 799-803 (1994).
140. Chen LT, Lin JT, Shyu RY et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J. Clin. Oncol. 19(22), 4245-4251 (2001).
141. Morgner A, Miehlke S, Fischbach W et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J. Clin. Oncol. 19(7), 2041-2048 (2001).
142. Daum S, Ulrich R, Heise W et al. Intestinal non-Hodgkins lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J. Clin. Oncol. 21(14), 2740-2746 (2003).
143. Habermann TM, Weller EA, Morrison VA et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J. Clin. Oncol. 24(19), 3121-3127 (2006).
144. Pfreundschuh M, Trumper L, Osterborg A et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 7(5), 379-391 (2006).
145. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N. Engl. J. Med. 346(4), 235-242 (2002).
146. Kato K, Sugitani M, Nagata T et al. A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. Gastrointest. Endosc. 53(3), 352-355 (2001).
147. Gonzalez Cueto D, Bruno S, Bustos Fernandez LM, Narbaitz M. Gastric solitary plasmacytoma associated with Helicobacter pylori infection. Acta Gastroenterol. Latinoam. 29(3), 119-123 (1999).
148. Shapiro M, Kimchi NA, Herbert M, Scapa E. Gastric plasmacytoma and Helicobacter pylori infection. J. Clin. Gastroenterol. 39(1), 56-57 (2005).
149. Wohrer S, Isaacson PG, Raderer M. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann. Hematol. 83(10), 666 (2004).
150. Papadaki HA, Skordilis P, Minadakis G et al. Complete regression of primary gastric plasmacytoma following Halicobacter pylori eradication. Ann. Hematol. 82(9), 589-592 (2003).
151. Grogan TM, Van Camp B, Kyle RA, Muller-Hermelink HK, Harris NL. Plasma cell neoplasms. In: Pathology and Genetics: Tumours of Haematopaietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARCPress, Lyon, France, 142-156 (2001).
152. Chetty R, Bramdev A, Reddy AD. Primary extramedullary plasmacytoma of the esophagus. Ann. Diagn. Pathol. 7(3), 174-179 (2003).
153. Morris WT, Pead JL. Myeloma of the oesophagus. J. Clin. Pathol. 25(6), 537-538 (1972).
154. Nolan KD, Mone MC, Nelson EW. Plasma cell neoplasms. Review of disease progression and report of a new variant. Surg. Oncol. 14(2), 85-90 (2005).
155. Ruiz Montes F, Rene Espinet JM, Buenestado Garcia J, Panades Siurana MJ, Egido Garcia R, Ramos Yanez J. Primary gastric plasmacytoma of rapid growth presenting with upper gastrointestinal bleeding. Am. J. Gastroenterol. 90(8), 1349-1350 (1995).
156. Fujiyoshi Y, Inagaki H, Tateyama H. Murase T, Eimoto T. Mott cell tumor of the stomach with Helicobacter pylori infection. Pathol. Int. 51(1), 43-46 (2001).
157. Ahmed N, Ramos S, Sika J, LeVeen HH, Piccone VA. Primary extramedullary esophageal plasmacytoma: first case report. Cancer 38(2), 943-947 (1976).
158. Sharma S, Singhal S, Kumar L, Shukla N, Rath GK. Primary gastric plasmacytoma. Trop. Gastroenterol. 12(3), 148-156 (1991).
159. Remigio PA, Klaum A. Extramedullary plasmacytoma of stomach. Cancer 27(3), 562-568 (1971).
160. Oguzkurt L, Karabulut N, Cakmakci E, Besim A. Primary non-Hodgkin's lymphoma of the esophagus. Abdom. Imaging 22(1), 8-10 (1997).
161. del Pozo Garcia AJ, Garcia Buey L, Llorca I et al. Relapsing upper bleeding in non-Hodgkin's oesophageal lymphoma associated with achalasia. Eur. J. Gastroenterol. Hepatol. 15(10), 1127-1130 (2003).
162. Recine MA, Perez MT, Cabello-Inchausti B, Lilenbaum RC, Robinson MJ. Extranodal lymphoplasmacytoid lymphoma (immunocytoma) presenting as small intestinal obstruction. Arch. Pathol. Lab. Med. 125(5), 677-679 (2001).
163. Nanni G, Bertoncini M, Garbini A, Pepoli R, Bergamini C. Primary lymphoblastic lymphoma of the ileocecal valve. Manifesting as an ileocecal intussusception. NY State J. Med. 83(2), 240-242 (1983).
164. Shimada-Hiratsuka M, Fukayama M, Hayashi Y et al. Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer 80(2), 292-303 (1997).
165. Kikuchi M, Jaffe ES, Ralfkiaer E. Adult T-cell leukaemia/lymphoma. In: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARCPress, Lyon, France, 200-203 (2001).
166. Foss HD, Schmitt-Graff A, Daum S et al. Origin of primary gastric T-cell lymphomas from intraepithelial T-lymphocytes: report of two cases. Histopathology 34(1), 9-15 (1999).
167. Hatano B, Ohshima K, Katoh A et al. Non-HTLV-1-associated primary gastric T-cell lymphomas show cytotoxic activity: clinicopathological, immunohistochemical characteristics and TIA-1 expression in 31 cases. Histopathology 41(5), 421-436 (2002).
168. Tsukada T, Ohno T, Kihira H et al. Primary esophageal non-Hodgkin's lymphoma. Intern. Med. 31(4), 569-572 (1992).
169. Fujisawa S, Motomura S, Fujimaki K et al. Primary esophageal T cell lymphoma. Leuk. Lymphoma 33(1-2), 199-202 (1999).
170. Niitsu N, Nakamine H, Kohri M et al. Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature. Ann. Hematol. 82(3), 197-202 (2003).
171. Isomoto H, Nishida Y, Fukuda H et al. Two cases of adult T-cell leukaemia/lymphoma with oesophageal involvement. Eur. J. Gastroenterol. Hepatol. 14(4), 449-452 (2002).
172. Isomoto H, Ohnita K, Mizuta Y et al. Clinical and endoscopic features of adult T-cell leukemia/lymphoma with duodenal involvement. J. Clin. Gastroenterol. 33(3), 241-246 (2001).
173. Hidaka H, Hotokezaka M, Iwamura T et al. Primary, solitary, adult T-cell leukemia/lymphoma of the descending colon. J. Gastroenterol. 39(8), 788-792 (2004).
174. Cellier C, Delabesse E, Helmer C et al Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 356(9225), 203-208 (2000).
175. Daum S, Weiss D, Hummel M et al. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 49(6), 804-812 (2001).
176. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of
177. Zhang WY, Li GD, Liu WP et al. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin. Med. J. (Engl.) 118(18), 1542-1548 (2005).
178. Quintanilla-Martinez L, Lome-Maldonado C, Ott G et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 89(2), 644-651 (1997).
179. de Bruin PC, Jiwa NM, Oudejans JJ, Radaszkiewicz T, Meijer CJ. Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with glutensensitive enteropathy, pathological features, and immunophenotype. Am. J. Pathol. 146(4), 861-867 (1995).
180. Walsh SV, Egan LJ, Connolly CE, Stevens FM, Egan EL, McCarthy CF. Enteropathy-associated T-cell lymphoma in the west of Ireland: low-frequency of Epstein-Barr virus in these tumors. Mod. Pathol. 8(7), 753-757 (1995).
181. Gascoyne RD, Muller-Hermelink HK, Chott A, Wotherspoon A. Intestinal T-cell lymphoma. In: Pathology and Genetics: Tumours of the Digestive System. Hamilton SR, Aaltonen LA (Eds). IARCPress, Lyon, France, 87-89 (2000).
182. Isaacson PG, Wright DH, Ralfkiaer E, Jaffe ES. Enteropathy-type T-cell lymphoma. In: Pathology and Genetics: Tumours of haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). IARC Press, Lyon, France, 208-209 (2001).
183. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH, Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J. Clin. Oncol. 18(4), 795-803 (2000).
184. Isaacson P, Wright DH. Intestinal lymphoma associated with malabsorption. Lancet 1, 67-70 (8055) (1978).
185. -T-cell lymphomas of monomorphic small to medium size histology. Am. J. Pathol. 153(5), 1483-1490 (1998).
186. Dieter RS, Duque K. Enterotherapy associated T-cell lymphoma: a case report and literature review. WI Med. J. 99(7), 28-31 (2000).
187. Ruskone-Fourmestraux A, Rambaud JC. Gastrointestinal lymphoma: prevention and treatment of early lesions. Best Pract. Res. Clin. Gastroenterol. 15(2), 337-354 (2001).
188. Chan JK, Sin VC, Wong KF et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89(12), 4501-4513 (1997).
189. Ko YH, Cho EY, Kim JE et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology 44(5), 480-489 (2004).
190. Chim CS, Au WY, Shek TW et al. Primary CD56 positive lymphomas of the gastrointestinal tract. Cancer 91(3), 525-533 (2001).
191. Jaffe ES. Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis. Mod. Pathol. 15(3), 255-263 (2002).
192. Jaffe ES, Chan JK, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 20(1), 103-111 (1996).
193. Carbonnel F, d'Almagne H, Lavergne A et al. The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut 45(5), 662-667 (1999).
194. Taal BG, Van Heerde P, Somers R. Isolated primary oesophageal involvement by lymphoma: a rare cause of dysphagia: two case histories and a review of other published data. Gut 34(7), 994-998 (1993).
195. Hosoya Y, Yokoyama T, Arai W et al. Tracheoesophageal fistula secondary to chemotherapy for malignant B-cell lymphoma of the thyroid: successful surgical treatment with jejunal interposition and mesenteric patch. Dis. Esophagus 17(3), 266-269 (2004).
196. Rawis RA, Vega KJ, Trotman BW. Small bowel lymphoma. Curr. Treat. Options Gastroenterol. 6(1), 27-34 (2003).